{"name":"John P. Bilezikian","slug":"john-p-bilezikian","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBGYWxfNWJla1Bqek5nTmY2YU9hclZMalJpSHpHRlFZU2VhMnlRcjRhQThQR2d1Q25Ec2RsYlNMR3JKVFo2OXdtbktGOEdmajB4ZW1VbzNrU1MxS1d1SWc?oc=5","date":"2018-06-25","type":"pipeline","source":"NEJM","summary":"The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis - NEJM","headline":"The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFAwLWl4QmtwN3d1RlNOVi1XX1lWWFg2dkJGNEI0bjFpcy1OaUNTNDVTR3NiR01FcTdVX1hqUFF2S1NxMVJ5eFhmNmR2YktOLU8xRTJUM1V4S2ZtOHFmZEJpQVBxVDhEVmR5Q0E?oc=5","date":"2017-05-29","type":"pipeline","source":"Wiley Online Library","summary":"Osteoporosis in Crisis: It's Time to Focus on Fracture - Binkley - 2017 - Journal of Bone and Mineral Research - Wiley Online Library","headline":"Osteoporosis in Crisis: It's Time to Focus on Fracture - Binkley - 2017 - Journal of Bone and Mineral Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBraHh1ZExpdkFmcWI5ZDhjYlVILU1SNWNoVzZQbUhmQjhnczhJODNyZXhUT0ZxdVVHZUNNelVuX3BpV1J4ODNvX3U1RFY2ZzBSTUREdHl2WFFLWVVJVlBiZmdzaWF5QQ?oc=5","date":"2015-11-17","type":"pipeline","source":"Wiley Online Library","summary":"Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72‐Hour Fast - Abraham - 2015 - Case Reports in Endocrinology - Wiley Online Library","headline":"Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72‐Hour Fast ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9GeHFqZDh6WXVBSHJLSEhOUHZtT3dKaW5wbHRHbUYxcTI2a2NILWp6U0tERjVQdVpkN0hPdHZOc25Dc1hZcVpMeFVITWhhX25pWlZTc2VCSzk?oc=5","date":"2014-12-16","type":"pipeline","source":"nature.com","summary":"New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide - nature.com","headline":"New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9FTWMwREhEak1LWkVyLXI5MENrUFFZSk9MM0JGX2FYUFdiaVU2Sk5TbVEyeHVRajJDV2poRkJFXzlwazU5NmFlWHpuTVBXalJVMHd6anJIMXpibDhDcndn?oc=5","date":"2005-08-11","type":"pipeline","source":"NEJM","summary":"One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis - NEJM","headline":"One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1xUWZMdDdHNl84RUdRdDM4ejdYcjd5SkUzUzd2U1BpaUE4dnNsamhQaVpmWjl6N01VYUxaOEtXN2dYaHU1cmZKVkVvMC1IRU4wbFFkVmdNZzk2SjJuNkNfR0NocVc1aW9L?oc=5","date":"1997-11-20","type":"pipeline","source":"NEJM","summary":"Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary Hyperparathyroidism - NEJM","headline":"Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary Hyperparat","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}